COYA
Coya Therapeutics, Inc.
There isn't enough reported data to score COYA yet.
OSCR
Oscar Health, Inc.
OSCR's fundamentals are strong: revenue grew 55% and its operating margin went from −1.9% to 5.4%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
COYA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Weak | |
| Unavailable |
COYA's revenue is currently stable, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
OSCR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Strong | |
| Strong |
OSCR's revenue, profitability, cash flow and balance sheet are all currently healthy.
COYA PE Valuation
COYA has no meaningful PE right now: it lost money over the past year.
OSCR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $31.94 | — |
| Current | 13x | $31.94 | — |
| Cheap | 21x | $52.73 | +65% |
| Fair | 35x | $87.23 | +173% |
| Expensive | 130x | $322 | +907% |
Historical ranges are pointers, not guarantees.
OSCR's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.
COYA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Strong growth | |
| -- | |
| Limited | |
| Moderate |
Analysts expect COYA's revenue to grow, with its earnings and profitability holding steady.
OSCR Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for OSCR, with profitability improving.
COYA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.39 | -$0.28 |
| Q2 2026 | -$1.07 | +$0.17 |
| Q1 2026 | -$1.15 | -$0.08 |
| Q4 2025 | -$1.27 | -$0.29 |
| Q3 2025 | -$1.11 | -$0.45 |
| Q2 2025 | -$1.24 | -$0.50 |
| Q1 2025 | -$1.07 | -$0.21 |
| Q4 2024 | -$0.98 | -$0.19 |
COYA is still losing money, but less than at its worst: $1.39 per share over the past year, against $1.64 at its worst in early 2023.
OSCR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.61 | +5.6% |
| Q3 2026 | $2.47 | +$3.47 |
| Q2 2026 | $1.45 | +$2.14 |
| Q1 2026 | -$0.54 | -235% |
| Q4 2025 | -$1.69 | -1790% |
| Q3 2025 | -$1.00 | -$0.92 |
| Q2 2025 | -$0.69 | -$0.54 |
| Q1 2025 | $0.40 | +$0.82 |
| Q4 2024 | $0.10 | +$1.32 |
OSCR has the edge over COYA on earnings quality, reporting a profit while its opponent remains loss making.
COYA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $234.1K | -93% |
| Q2 2026 | $243.7K | +49% |
| Q1 2026 | $251.1K | -2.6% |
| Q4 2025 | $4M | +202769% |
| Q2 2025 | $163.6K | -95% |
| Q1 2025 | $257.9K | +103% |
COYA's revenue is growing: $234,134 last quarter, down 93% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -4676% | -4608 points |
| Q2 2026 | -2891% | +1029 points |
| Q1 2026 | -3042% | -65 points |
| Q4 2025 | -152% | +208879 points |
| Q3 2025 | -68% | N/A |
| Q2 2025 | -3920% | -3826 points |
| Q1 2025 | -2977% | +1346 points |
| Q4 2024 | -209032% | N/A |
COYA's operating margin was −4676% last quarter, down 4608 points from the same quarter a year ago, near the bottom of its range since 2024.
OSCR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.1B | +72% |
| Q2 2026 | $4.9B | +70% |
| Q1 2026 | $4.6B | +53% |
| Q4 2025 | $2.8B | +17% |
| Q3 2025 | $3B | +23% |
| Q2 2025 | $2.9B | +29% |
| Q1 2025 | $3B | +42% |
| Q4 2024 | $2.4B | +67% |
OSCR has the edge over COYA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.5% | +7.8 points |
| Q2 2026 | 8% | +16 points |
| Q1 2026 | 15% | +5.4 points |
| Q4 2025 | -12% | -5.7 points |
| Q3 2025 | -4.3% | -2.3 points |
| Q2 2025 | -8.1% | -11 points |
| Q1 2025 | 9.8% | +1.1 points |
| Q4 2024 | -6.2% | +4 points |
OSCR has the edge over COYA on profitability, with a higher operating margin.
COYA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$7.2M | -$6.1M |
| Q2 2026 | -$7.4M | -$1.6M |
| Q1 2026 | -$6.2M | -$3.4M |
| Q4 2025 | -$1M | +$1.4M |
| Q3 2025 | -$1.1M | +$4.3M |
| Q2 2025 | -$5.8M | -$1.2M |
| Q1 2025 | -$2.8M | -232% |
| Q4 2024 | -$2.4M | -$168.7K |
COYA has burned cash in almost every quarter: −$22M over the past year, against −$12M the year before.
OSCR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -$238.2M |
| Q2 2026 | $2.1B | +316% |
| Q1 2026 | $2.6B | +200% |
| Q4 2025 | $662.8M | +95% |
| Q3 2025 | -$973.7M | -$466M |
| Q2 2025 | $499.8M | +2.1% |
| Q1 2025 | $869.5M | +38% |
| Q4 2024 | $340M | +17% |
OSCR has the edge over COYA on cash generation, producing positive trailing cash flow while its opponent burns cash.
COYA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +622 shares |
| 1 year | +40% | +6.7M shares |
| 3 years | +141% | +13.7M shares |
| 5 years | +806% | +20.9M shares |
COYA has 23M diluted shares, up 40% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
OSCR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.9% | +13M shares |
| 1 year | +34% | +87.2M shares |
| 3 years | +55% | +123M shares |
| 5 years | +66% | +138M shares |
| Available history | +71% | +143M shares |
OSCR has the edge over COYA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
COYA Net Leverage
COYA's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
OSCR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -4.2x | Net Cash |
| Q2 2026 | -5.5x | Net Cash |
| Q1 2026 | -110.0x | Net Cash |
| Q1 2025 | -9.7x | Net Cash |
| Q4 2024 | -13.7x | Net Cash |
| Q3 2024 | -10.1x | Net Cash |
| Q2 2024 | -24.0x | Net Cash |
| Q1 2024 | -217.7x | Net Cash |
OSCR has more cash than debt.
COYA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.9 | Neutral |
| Stochastic | 10.7 | Oversold |
COYA's weekly RSI is 37 (neutral) and its Stochastic is 11 (oversold).
OSCR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.7 | Neutral |
| Stochastic | 44.9 | Neutral |
OSCR's weekly RSI is 59 (neutral) and its Stochastic is 45 (neutral).
COYA PE vs Healthcare Sector
COYA has no meaningful PE right now: it lost money over the past year.
OSCR PE vs Healthcare Sector
| Metric | OSCR | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 26x | 50% below |
| PE % | 3 | 35 | 32 pts below |
OSCR is trading at 13x earnings, a 50% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
COYA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.11 | 20% below |
| 20 week MA | $4.50 | 27% below |
| 50 week MA | $4.67 | 30% below |
| 100 week MA | $5.37 | 39% below |
| 200 week MA | $5.69 | 43% below |
COYA is in a downtrend: it's below all five of its weekly moving averages, and 43% below its 200-week average.
OSCR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $31.2 | 2.3% above |
| 20 week MA | $31.1 | 2.8% above |
| 50 week MA | $22.9 | 39% above |
| 100 week MA | $19.3 | 65% above |
| 200 week MA | $15.5 | 106% above |
OSCR has the edge over COYA on trend strength, trading above more of its moving averages.
COYA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $4.74 | $7.41 | +56% |
| 2024 | $7.41 | $5.92 | -20% |
| 2025 | $5.92 | $5.47 | -7.6% |
| 2026 YTD | $5.47 | $3.27 | -40% |
COYA has finished lower in two of the last three years. It's down 40% so far in 2026.
OSCR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $31.0 | $8.02 | -74% |
| 2022 | $8.02 | $2.21 | -72% |
| 2023 | $2.21 | $9.15 | +314% |
| 2024 | $9.15 | $13.8 | +51% |
| 2025 | $13.8 | $14.9 | +8% |
| 2026 YTD | $14.9 | $31.9 | +114% |
OSCR has the edge over COYA on returns for 2026, with the stronger performance.